Merck Breaks Ground on $3 Billion Pharmaceutical Manufacturing Facility in Elkton, Virginia

According to a report on Merck KGaA's official website on October 20, Merck announced the groundbreaking of a pharmaceutical facility at its plant in Elkton, Virginia, USA, with an investment of $3 billion. Merck stated that this investment is part of its plan to invest over $70 billion starting this year to expand production, manufacturing, and R&D within the United States.

(This article is from Yicai)